PD-1 inhibitor combined with ablation in liver metastasis: A retrospective, multicenter study. This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I. This abstract does not include a ...
(RTTNews) - ANGLE plc (AGL.L, ANPCY) said that it has reached an agreement with AstraZeneca PLC, to develop and validate a methodology leveraging ANGLE's existing DNA damage response or "DDR" assay ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback